Identification of nontuberculous mycobacteria species by multiplex real-time PCR with high-resolution melting

Abstract

INTRODUCTION:  Nontuberculous mycobacteria (NTM) species, as human pathogens, are increasing in the world, as is the difficulty of accurately identifying them. Differential diagnosis, especially between the M. tuberculosis complex and NTM species, and the characterization of NTM species is important. This study aimed to evaluate the performance of a molecular system based on multiplex real-time PCR with high-resolution melting (HRM) for the identification and differentiation of NTM species of clinical importance of an endemic area for tuberculosis in northeastern Brazil.

METHODS:  The technical protocol of the molecular system was based on multiplex real-time PCR-HRM, and evaluated the sensitivity and specificity of the detection of NTM species in mycobacterial clinical isolates from the studied region. The gold standard method was specific gene sequencing.

RESULTS:  The sensitivity and specificity of multiplex real-time PCR-HRM modified for differentiation between NTM and M. tuberculosis were 90% and 100%, respectively. The PCR-HRM sensitivities for the characterization of NTM species (M. kansasii, M. abscesses, M. avium, and M. fortuitum) were 94.59%, 80%, 57.14%, and 54%, respectively.

CONCLUSIONS  The multiplex real-time PCR-HRM modified assay has the potential to rapidly and efficiently identify nontuberculous mycobacteria of clinical importance, which is crucial for immediate implementation of the appropriate therapy and thus avoiding complications and sequelae in patients.

Keywords: Identification; Non-tuberculous mycobacteria; PCR multiplex real-time; Diagnosis; Brazil

INTRODUCTION

Nontuberculous mycobacteria (NTM) consist of species of the genus Mycobacterium, but with distinct characteristics from Mycobacterium tuberculosis¹. Tuberculosis (TB) remains a serious public health problem; however, infections caused by nontuberculous mycobacteria have been increasingly recognized as pathologies in humans^2,3. NTM are opportunistic organisms, with more than 199 species and 14 subspecies described, which can be found in soil or water. They are opportunistic pathogens in humans, causing a wide variety of skin and soft tissue infections, lymphadenitis, and lung disease in immunocompromised and immunocompetent individuals^4,5,6.

Data from recent studies have demonstrated an increasing prevalence of NTM infections around the world, especially associated with immunosuppression and post-surgical infections^3,7. The increase in NTM infections is worrisome, mainly due to the diversity of species found and the symptom similarity with infections caused by complex M. tuberculosis⁸. The epidemiology of NTM infection differs among countries, and the data vary widely. Therefore, it is important to characterize the distribution of NTM infection by demographics to optimize disease control.

In Brazil, a country with high endemicity for TB (20^th position according to WHO classification), the prevalence and incidence of NTM infections are not well known since the disease does not require compulsory notification for the health system. The isolation of NTM species in Brazil differs according to the region; however, it is possible to observe a predominance of Mycobacterium avium complex (MAC), such as M. avium, and M. intracellulare, M. kansasii, and M. fortuitum, causing active NTM disease^1,9,10.

The correct differentiation between M. tuberculosis complex and NTM infections is crucial for the immediate implementation of the appropriate therapy. Although classical methods for the identification of mycobacterial species are still used, they are limited. The gold standard method for the identification of NTM species is DNA sequencing¹¹, owing to its highly discriminatory nature. However, equipment and running costs are high and are not available in most laboratories in Brazil. The hsp65, rpoB, and 16S rRNA genes are more commonly used for sequencing assays¹².

Laboratory methods for improving the detection of NTM species are needed because it is important to identify the species that cause NTM infection to start specific treatment and thus avoid complications and sequelae in patients. Thus, we adapted and evaluated the performance of a multiplex real-time PCR with high resolution melting (HRM) assay¹³ for the accurate and rapid identification of NTM species isolated from cultures of clinical importance from a northeastern region of Brazil with a high prevalence of tuberculosis. The study was developed to evaluate a specific molecular identification method to be used as clinical and laboratory support.

METHODS

This study was descriptive and analysis was carried out to evaluate the performance of the PCR-HRM multiplex real-time technique in relation to DNA sequencing (gold standard) in strains of Mycobacterium sp. obtained from culture in Löwenstein-Jensen medium, initially found by phenotypic and biochemical tests in the identification and characterization of NTM species for diagnostic definition.

Mycobacterium species reference strains and cultures of suspected mycobacteriosis

Reference strains of eight Mycobacterium species were used, provided by the American Type Culture Collection (ATCC) and the National Institute for Quality Control in Health-INCQS/FIOCRUZ: Mycobacterium species reference (M. tuberculosis ATCC 25618 (INCQS 00136); Mycobacterium avium ATCC 25291(INCQS 00273); Mycobacterium fortuitum ATCC 6841 (INCQS 00142); Mycobacterium intracelullare ATCC 13950; Mycobacterium kansasii ATCC 12478 (INCQS 00134); Mycobacterium abscessus ATCC 19977 (INCQS 00631); Mycobacterium chelone ATCC 35752; and Mycobacterium smegmatis ATCC 607 (INCQS 00061).

Seventy-nine isolates from cultures of mycobacteriosis were provided by laboratory diagnosis in Pernambuco, Brazil (LACEN-PE-Brazil) between January 2012 and June 2014 and were defined based on the American Thoracic Society (ATS)¹⁴. These isolates were kept in Löwenstein-Jensen medium and incubated at 37 °C for eight weeks^15,16.

DNA extraction

After growth in Löwenstein-Jensen medium, Mycobacterium colonies were suspended in 200 μL of ultrapure water, boiled for 20 min at 99 °C, then frozen at -20 °C for another 20 min. They were centrifuged for pellet formation and stored in a freezer at -80 °C, according to the National Manual of Tuberculosis Vigilance and other Mycobacteria¹⁶. The pellet was used in the real-time PCR assay.

Multiplex real-time PCR with high-resolution melting (HRM) method

Genomic DNA extracted from the Mycobacterium reference strains and mycobacterial culture isolates was identified using a multiplex real-time PCR-HRM assay, previously developed¹³, with modifications performed. The modifications involved the use of a combination of primers in the different steps of the amplification reactions. They were performed to initially differentiate between Mycobacterium tuberculosis and nontuberculous mycobacteria, because this region has a high endemicity for TB. In addition, the following steps were performed to identify NTM species based on the frequency and distribution of those frequently isolated by the reference laboratory for mycobacterioses from Pernambuco, Brazil.

Real-time multiplex PCR-HRM was performed in three steps. Step 1: differentiation between M. tuberculosis and NTM, in which the primers used in this reaction were M. tuberculosis, NTM, and internal control. The bacterial 16S rRNA gene was chosen as a target gene for the internal control^2,15. Step 2: identification of NTM species detected in Step 1. In Mix II, primers were used to differentiate the species M. avium, M. intracellulare, M. kansasii, and M. abscessus. Step 3: identification of NTMs that were not identified in Step 2. In Mix III, the primers were used only for M. fortuitum, M. chelonae, and M. smegmatis (Table 1).

TABLE 1:
Targets and primers used in multiplex real-time PCR-HRM.

	PRIMER	Target	5′→3′	Reference	Tm
MIX I	Internal control	16S rRNA	ATGGCTGTCGTCAGCTCGTG	Cha, 2014; Amann et al.,1995	80.08 ±0.36
			GCTCGTTGCGGGACTTAACC
	MTC	IS6110	CGAACTCAAGGAGCACATCAG	Kim, 2012	84.47 ±0.41
			CAGGGTTAGCCACACTTTGC
	NTM	16S rRNA	ATGTYTTSTGGKGSAAAGCTTT	Kim, 2012	88.14 ±0.51
			GTAGGAGTCTGGGCCGTA
MIX II	M.avium	16S rRNA	GGGTCTAATACCGGATAGGACCT	Kim, 2012	73.55 ±0.34
			CGCAAAAGCTTTCCACCAGA
	M.intracellulare	16S rRNA	GGTCTAATACCGGATAGGACCTTTAG	Kim, 2012	75.38 ±0.31
			GCAAAAGCTTTCCACCAAA
	M.kansasii	16S rRNA	CGGAAAGGTCTCTTCGGAGAC	Kim, 2012	81.42 ±0.20
			TTTCCCAGGCTTATCCTGGT
	M.abscessus	ITS	ATGAACTAGGGAACATAAAGTATGCA	Kim, 2012	72.72 ±0.74
			AGGATTTACAAAACATATTCACCAAGT
MIX III	M. fortuitum	ITS	CCCGAGCCGTGAGGAAC	Kim, 2012	81.65 ±0.26
			CAATAGTGTGTCTGGCAGTCAAAA
	M.chelonae	ITS	TGTCCACCCCGTGGATA	Kim, 2012	79.40 ±0.25
			GTGCCAGCGTTTCAATTCTA
	M.smegmatis	ITS	GAGCTGGAGCGCTGTAGTG	Kim, 2012	84.28 ±0.14
			GAAACAGCGTTTCCCACAC

• MTC: Mycobacterium tuberculosis complex; NTM: Nontuberculous mycobacteria.

Real-time multiplex PCR-HRM reactions were performed on a Rotor Gene 600S (Corbett Research, Cambridge, United Kingdom)) thermal cycler and contained 10 mmol/L primer mix, 2 × GRH PCR master mix (Qiagen Inc., Germantown, MD, USA), which included EvaGreen fluorescent dye, and 1.5 μL genomic DNA in a final volume of 10 μL. All reactions were performed in duplicate. Positive and negative controls and no-template controls were included in each run. The analytical sensitivity of the assay was determined using a 10-fold dilution (10 ng, 1 ng, 100 pg, 10 pg, 1 pg, 100 fg, 10 fg (equivalent to one bacillus) and 1 fg) standard curve of DNA isolated from M. tuberculosis H37Rv. The detection limit of the real-time PCR assay was 1 fg, equivalent to less than one bacillus (data not shown).

Standardization of melting temperatures (Tm)

The assay was initially evaluated using 8 reference strains and was performed using the standardized melting temperatures for multiplex real-time PCR-HRM reactions¹³. All experiments were performed in duplicate (Figure 1).

FIGURE 1:
Standardization of melting temperatures in multiplex real-time PCR-HRM nontuberculous mycobacteria.

Sequencing

The hsp65, rpoB, and 16S rRNA genes were sequenced^17,18,19. The amplified products were purified with the GFX PCR Kit for DNA and Gel Band Purification (GE Healthcare, Buckinghamshire, UK) according to the manufacturer's recommendations. Sequencing of the 79 clinical strains was performed on an ABI3130 (Life Technologies, California, United States) using the National Reference Laboratory for Tuberculosis of the Reference Center Professor Hélio Fraga/ENSP/FIOCRUZ. All sequences obtained were compared on the basis of similarity to those in the GenBank database using BLAST for species identification (http://blast.ncbi.nlm.nih.gov/Blast.cgi).

Data analysis

Specific gene sequencing was considered the gold standard for calculating real-time multiplex PCR-HRM performance. Statistical analysis was performed using the BioEstat 5.0 program. For the confirmation of the Tm for each NTM strain, we used the ANOVA variance with the Tukey test.

Sensitivity and specificity values were calculated to evaluate the real-time multiplex PCR-HRM system. The kappa index was used to evaluate the degree of agreement between the tests. Calculations were performed using the OpenEpi version 3.1 statistical software.

Ethics approval

The study was approved by the ethical committee of the Aggeu Magalhães Institute, Oswaldo Cruz Foundation CAAE: 07382012.4.0000.5190.

RESULTS

A total of 79 specimens were tested for the presence of mycobacteria during the study period. Multiplex real-time PCR with high-resolution melting (HRM) results as well as the results of DNA sequencing, which was used as the gold standard method assay, are shown in Table 2. NTM species were identified in 70 (88.60%) of the samples and the M. tuberculosis complex was identified in 9 (11.40%) of the samples.

TABLE 2:
Comparison between real-time PCR-HRM and sequencing of specific genes of the studied Mycobacterial species.

Species identified by real-time multiplex PCR-HRM	Species identified by specific gene sequencing
	M. avium	M.intracellulare	M. kansasii	M.abcessus	M. fortuitum	M. tuberculosis	NTM	Not identified	Total
M. avium	4
M. intracellulare
M. kansasii			35
M. abcessus				8
M. fortuitum					6
M. tuberculosis	1		2	2	1	9	1
NTM							4
Not identified	2				4
Total	7	0	37	10	11	9	5	0	79

• NTM: Nontuberculous mycobacteria.

The Tm averages obtained for each species in the real-time multiplex PCR-HRM are presented in Table 1; due to technical problems, it was not possible to standardize the Mycobacterium chelonae. There was a significant statistical difference when comparing the Tm values of all species used in the study (p <0.01).

Step 1 of the multiplex real-time PCR-HRM assay was performed on the 79 (100%) mycobacterial culture isolates. It detected 63 (79.74%) NTM and 16 (20.26%) M. tuberculosis complex species. The sensitivity and specificity were 90% (CI = 80.77-95.07) and 100% (CI = 70.8-100), respectively, with an accuracy value of 91%. Specific gene sequencing and real-time multiplex PCR-HRM showed good agreement, as demonstrated by a kappa index of 0.67 (p <0.0001) (Figure 2).

FIGURE 2:
Analysis of the curve of real-time multiplex PCR-HRM: M. tuberculosis and NTM.

The 63 clinical isolates identified as nontuberculous mycobacteria in Step 1, proceeded to Steps 2 and 3 of the real-time multiplex PCR-HRM for the differentiation of NTM species. In step 2, 35 (55.55%) isolates were identified as M. kansasii, 8 (12.69%) as M. abscessus, and 4 (6.37%) as M. avium. The sensitivities were 94.59% (CI = 82.3-98.5), 80% (CI = 49.02-94.33) and 57.14% (CI= 25.05-84.18), respectively (Table 2). The specific gene sequencing and multiplex real-time PCR-HRM showed good agreement, as demonstrated in each species identified by the kappa index: k 0.935 (p < 0.001) for M. kansasii, k 0.871 (p < 0.001) for M. abscessus, and k 0.571 (p < 0.001) for M. avium.

In Step 3, only M. fortuitum species were identified in 6 (9.52%) isolates, showing a sensitivity of 54% (CI = 25.05-84.18) and a kappa index of 0.665 (p < 0.001). It was not possible to identify 10 mycobacterial isolates (15.87%) at the end of all stages of the multiplex real-time PCR-HRM assay. The sequencing identified 4 isolates as M. fortuitum, 2 as M. avium, 1 as M. wolinsky, and 3 as M. celeriflavum. The multiplex real-time PCR-HRM assay did not have specific primers for the identification of M. wolinsky and M. celeriflavum (Table 2).

DISCUSSION

In the present study, we aimed to modify the combination of the primers used in the three different steps of real-time multiplex PCR-HRM, previously published¹³_. Initially, we differentiated between M. tuberculosis and NTM, at stage 1 of PCR, because this region presents high tuberculosis endemicity, since the northeastern region is the second in Brazil in new cases of tuberculosis^21,22, reducing the number of species identification necessary in the next steps (2 and 3). In Steps 2 and 3, accurate identification was performed for NTM species with the highest prevalence in the region (M. avium, M. intracellulare, M. kansasii, M. abcessus, and M. fortuitum). An advantage of this system is the PCR conditions of the reaction: Steps 1, 2, and 3 were designed to be equivalent and the reactions could be performed simultaneously while the assay was run. The assay was able to identify approximately 84% of the NTM species evaluated, with precise identification of species and subspecies evaluated.

The multiplex real-time PCR-HRM was able to perform species differentiation using different melting temperatures. In Step 1, it was observed that of the 16 species identified as Mycobacterium tuberculosis complex by multiplex real-time PCR-HRM, 7 were NTM species isolates, found by specific gene sequencing (2 M. kansasii, 2 M. abcessus, 1 M. fortuitum, 1 M. avium, and 1 M. interjectum), which were characterized as false positives. Kim and collaborators²³ explain that it can be difficult to interpret melting curves in cases involving mixed sequences or strains with a variation in the target sequences. They found that the reactions of the hydrolysis probe assay have advantages over the assay that employs melting curve analysis because the analyses of amplification curves are simpler.

Of the 37 M. kansasii isolates identified by specific gene sequencing, the multiplex real-time PCR-HRM, Step 2, identified 35 as M. kansasii and 2 as M. tuberculosis (considered false-positive), in which solid culture identified these 2 isolates as slow-growing. Of the M. avium isolates, 7 species were identified by sequencing. However, the multiplex real-time PCR-HRM identified 4 isolates as M. avium 1 as M. tuberculosis (considered false positive), which was identified by solid culture as slow-growing, and 2 were not identified in any of the steps of PCR. The 16S rRNA gene was the molecular target used for the design of primers to detect NTM species. However, this gene has highly similar sequences in different Mycobacterium species, so it may not distinguish closely related species. To overcome these limitations, efforts have focused on the use of other genes such as hsp65 and rpoβ for accurate identification of NTM species²⁴. Sampling variability associated with low concentrations of 251 and 16S target sequences, both of which occur as single copies in the genomes as well as the differences in amplification efficiency, may explain the differences in detection²⁵.

In the M. abcessus isolates, 10 were identified by sequencing, but the multiplex real-time PCR-HRM identified 8 as M. abcessus and 2 as M. tuberculosis (considered false positive). Specific gene sequencing identified 11 species of M. fortuitum, in which 6 of these were identified in multiplex real-time PCR-HRM, 1 was identified as M. tuberculosis (false-positive result), and 4 were not identified in any of the steps. However, the 2 isolates of M. abcessus and M. fortuitum were identified in the solid culture as rapid-growth. The discordant results may be due to the genetic variability in the molecular target, the limited specificity of primers in the clusters used, or the limitation of the efficient PCR methodology used, highlighting the importance of further studies with different cluster profiles²⁴.

It was not possible to identify 4 mycobacterial isolates by multiplex real-time PCR-HRM, because there are no specific primers for these species (M. wolinski and M. celeriflarum). This isolate was identified only by specific gene sequencing (1 as M. wolinski and 3 as M. celeriflarum), considering the non-prediction of mycobacterial isolation of these species in the studied region. Although the multiplex real-time PCR-HRM assay was able to identify the M. intracellulare, M. chelonae, and M. smegmatis species, sampling did not confirm these species. The kappa index assessed at all stages of mycobacterial identification maintained the classification between strong (substantial) and moderate.

Studies have used real-time PCR techniques to differentiate between NTM infections and TB^17,20,23. Chen et al.²⁴ demonstrated that an in-house PCR-HRM assay targeting two genes, 16S rRNA and hsp65, could successfully differentiate at least 14 NTM species, including 8 slow- and 6-rapid growth, of clinically relevance.

The molecular differentiation of NTM species has led to recent advances, mainly due to the recognition of the importance of these bacteria with pathogenic potential to humans. Studies of methods and molecular markers, which discriminate between NTM species, are scarce in the scientific literature. Therefore, research is urgently required. However, we concluded that the use of a variety of genetic targets applied in molecular diagnostic testing provides greater precision in differentiating between the Mycobacterium tuberculosis complex and NTM. Thus, the identification of NTM species through routine molecular diagnostic tools is an alternative to the rapid diagnostic definition of this infection. Even though cumbersome and expensive to use routinely, it is necessary due to the burden on public health.

In this study, it was possible to differentiate between TB and NTM infections with precision, demonstrating its usefulness as a tool for the rapid differential diagnosis of TB and NTM disease. In order to characterize the NTM species, despite the limited sensitivity, an alternative and cheaper technique than the sequencing standard can be considered, mainly for the identification of the species M. abscessus, M. fortuitum, M. avium complex, M. kansasii.

The multiplex real-time PCR-HRM modified assay has the potential to identify rapid and efficient nontuberculous mycobacteria of clinical importance, which is crucial for immediate implementation of the appropriate therapy and thus avoiding complications and sequelae in patients.

ACKNOWLEDGEMENTS

This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brazil (CAPES) - Finance Code 001. We thank the staff of the Laboratory of Immunoepidemiology and the professionals involved. We thank the Reference Center Professor, Hélio Fraga, for the transfer of technology and the Central Laboratory of Public Health of Pernambuco (LACEN-PE).

REFERENCES

• ¹ Carneiro MDS, Nunes LDS, David SMMD, Dias CF, Barth AL, Unis G. Nontuberculous mycobacterial lung disease in a high tuberculosis incidence setting in Brazil. J Bras Pneumol. 2018;44(2):106-11.
• ² Leão SC, Martin A, Mejia G, Palomino JC, Robledo J, Telles MAS, et al. Practical handbook for the phenotypic and genotypic identification of mycobacteria. 1 ed. Brugges: Vanden Broele; 2005. p.164p.
• ³ Cowman S, Wilson R, Loebinger MR. Opportunistic mycobacterial diseases. Med. 2012;44(6):390-2.
• ⁴ Euzeby JP. LPSN: List of prokaryotic names with standing in nomenclature: genus Mycobacterium 2014. [cited 2019 may 1] Available from: Available from: http://www.bacterio.net/mycobacterium.html
  » http://www.bacterio.net/mycobacterium.html
• ⁵ Gonzalez-Santiago TM, Drage LA. Nontuberculous mycobacteria: skin and soft tissue infections. Dermatol clin. 2015;33(3):563-77.
• ⁶ Van Ingen J. Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease. Clin Chest Med. 2015;36(1):43-54.
• ⁷ Nunes-Costa D, Alarico S, Dalcomo MP, Correia-Neves M, Empadinhas N. The looming tide of nontuberculous mycobacterial infections in Portugal and Brazil. Tuberculosis (Edinb).2016;96:107-19.
• ⁸ Tran AC, Halse TA, Escuyer VE, Musser KA. Detection of Mycobacterium avium complex DNA directly in clinical respiratory specimens: opportunities for improved turn-around time and cost savings. Diagn Microbiol Infect Dis. 2014;79(1):43-8.
• ⁹ Puga FG, Pocente RHC, Chimara E, Bollela VR. HIV-negative pulmonary disease caused by nontuberculous mycobacteria in Southern Brazil: clinical and microbiological characterization. J Thorac Dis. 2018;10(3):1903-11.
• ¹⁰ Da Costa ARF, Falkinham JO III, Lopes ML, Barretto AR, Felicio JS, Sales LHM, et al. Occurrence of nontuberculous mycobacterial pulmonary infection in an endemic area of tuberculosis. PLoS Negl Trop Dis. 2013; 7(7):e2340.
• ¹¹ Yin X, Zheng L, Wu L, Cao N, Zheng F, Hu Y, et al. Comparative evaluation of two rapid methods for differentiating mycobacteria. Tuberculosis (Edinb). 2013; 93(2):227-31.
• ¹² Jagielski T, Minias A, van Ingen J, Rastogi N, Brzostek A, Zaczek A, et al. Methodological and clinical aspects of the molecular epidemiology of Mycobacterium tuberculosis and other Mycobacteria Clin Microbiol. 2016; 29(2):239-90.
• ¹³ Kim J-U, Cha C-H, An H-K. Multiplex real-time PCR assay and melting curve analysis for identifying Mycobacterium tuberculosis complex and nontuberculous mycobacteria. J Clin Microbiol . 2012; 50(2):483-7.
• ¹⁴ Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. J Respir Crit Care Med. 2007;175(4):367-416.
• ¹⁵ Liu PI, McGregor DH, Faucher I, Jinks WL, Miller LA, Green L, et al. Comparison of three culture media for isolation of Mycobacterium tuberculosis: a 6-year study. Appl Environ Microbiol. 1973;26(6)880-3.
• ¹⁶ Ministério da Saúde (MS). Secretaria de Vigilância em Saúde. Sistema Nacional de Vigilância em Saúde - Manual nacional de vigilância laboratorial da tuberculose e outras micobactérias. 1º edição. Brasília: MS; 2008. 458 p.
• ¹⁷ Adékambi T, Colson P, Drancourt M. rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria. J Clin Microbiol. 2003;41(12):5699-708.
• ¹⁸ Kim K, Lee H, Lee MK, Lee SA, Shim TS, Lim SY, et al. Development and application of multiprobe real-time PCR method targeting the hsp65 gene for differentiation of Mycobacterium species from isolates and sputum specimens. J Clin Microbiol . 2010;48(9):3073-80.
• ¹⁹ Shin S, Kim EC, Yoon JH. Identification of nontuberculous mycobacteria by sequence analysis of the 16S ribosomal RNA, the heat-shock protein 65 and the RNA polymerase-subunit genes. Korean J Lab Med. 2006;26(3):153-60.
• ²⁰ Hoshino Y, Suzuki K. Differential diagnostic assays for discriminating mycobacteria, especially for nontuberculous mycobacteria: what does the future hold? Future Microbiol. 2015;10(2):205-16.
• ²¹ Brasil; Ministério da Saúde; Secretaria de Vigilância em Saúde. Brasil livre da tuberculose: evolução dos cenários epidemiológicos e operacionais da doença. Bol Epidemiol. 2019;50(10):1-18.
• ²² Busatto C, Vianna JS, Silva ABS, Basso R, Silveira J, Groll AV, et al. Nontuberculous mycobacteria in patients with suspected tuberculosis and the genetic diversity of Mycobacterium avium in the extreme south of Brazil. J Bras Pneumol . 2020;46(2):e20190184.
• ²³ Kim JU, Cha CH, An HK. Direct identification of mycobacteria from clinical specimens by multiplex real‐time PCR. J Appl Microbiol. 2015;118(6):1498-506.
• ²⁴ Kim SH, Shin JH. Identification of nontuberculous mycobacteria using multilocous sequence analysis of 16S rRNA, hsp65, and rpoB. J Clin Lab Anal. 2018; 32(1):e22184.
• ²⁵ Cha CH, An HK, Kim JU. Direct identification of mycobacteria from culture media using a multiplex real-time PCR assay: report on its application in a clinical laboratory in a region of high tuberculosis endemicity. Diagn Microbiol Infect Dis . 2014;79(1):49-53.

Publication Dates

• Publication in this collection
  06 Nov 2020
• Date of issue
  2020

History

• Received
  12 June 2020
• Accepted
  02 Sept 2020